Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Effect of Muscle Dysmorphia and Social Physique Anxiety on the Use of Supplements and Drugs

Yadollah Khorramabady 1 , *
Author Information
1 Department of Psychology, Payame Noor University, Hamedan, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: September 2017, 19 (9); e13541
  • Published Online: September 30, 2017
  • Article Type: Research Article
  • Received: May 16, 2017
  • Revised: June 20, 2017
  • Accepted: August 14, 2017
  • DOI: 10.5812/zjrms.13541

To Cite: Khorramabady Y. The Effect of Muscle Dysmorphia and Social Physique Anxiety on the Use of Supplements and Drugs, Zahedan J Res Med Sci. 2017 ; 19(9):e13541. doi: 10.5812/zjrms.13541.

Abstract
Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
Footnotes
References
  • 1. Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015; 13(1): 101-21[DOI][PubMed]
  • 2. Knapik JJ, Steelman RA, Hoedebecke SS, Austin KG, Farina EK, Lieberman HR. Prevalence of Dietary Supplement Use by Athletes: Systematic Review and Meta-Analysis. Sports Med. 2016; 46(1): 103-23[DOI][PubMed]
  • 3. Arent SM, Lutz RS. The Psychology of Supplementation in Sport and Exercise: Motivational Antecedents and Biobehavioral Outcomes. 2015; : 23-48[DOI]
  • 4. Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014; 24(5): 383-98[DOI][PubMed]
  • 5. Razavi Z, Moeini B, Shafiei Y, Bazmamoun H. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran. J Res Health Sci. 2014; 14(2): 163-6[PubMed]
  • 6. Abbate V, Kicman AT, Evans-Brown M, McVeigh J, Cowan DA, Wilson C, et al. Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health. Drug Test Anal. 2015; 7(7): 609-18[DOI][PubMed]
  • 7. Sagoe D, Torsheim T, Molde H, Schou Andreassen C, Pallesen S. Anabolic-Androgenic Steroid Use in the Nordic Countries: A Meta-Analysis and Meta-Regression Analysis. Nordic Studies on Alcohol and Drugs. 2015; 32(1)[DOI]
  • 8. Nakhaee MR, Pakravan F, Nakhaee N. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of iran. Addict Health. 2013; 5(3-4): 77-82[PubMed]
  • 9. Momaya A, Fawal M, Estes R. Performance-enhancing substances in sports: a review of the literature. Sports Med. 2015; 45(4): 517-31[DOI][PubMed]
  • 10. Kashi A. Drugs aids among Islamic Azad universities students in Zanjan province: Prevalence of use, knowledge of name, awareness about doping and risk factors associated to abuse. Res Educ Sport. 2016; 4(9): 31-42
  • 11. Mitchell L, Murray SB, Cobley S, Hackett D, Gifford J, Capling L, et al. Muscle Dysmorphia Symptomatology and Associated Psychological Features in Bodybuilders and Non-Bodybuilder Resistance Trainers: A Systematic Review and Meta-Analysis. Sports Med. 2017; 47(2): 233-59[DOI][PubMed]
  • 12. Smith D, Rutty MC, Olrich TW. Chemically Modified Bodies. 2016; : 31-50
  • 13. Nieuwoudt JE, Zhou S, Coutts RA, Booker R. Symptoms of muscle dysmorphia, body dysmorphic disorder, and eating disorders in a nonclinical population of adult male weightlifters in Australia. J Strength Cond Res. 2015; 29(5): 1406-14[DOI][PubMed]
  • 14. Babusa B, Tury F. Muscle dysmorphia in Hungarian non-competitive male bodybuilders. Eat Weight Disord. 2012; 17(1)-53[PubMed]
  • 15. Boyda D, Shevlin M. Childhood victimisation as a predictor of muscle dysmorphia in adult male bodybuilders. The Irish Journal of Psychology. 2011; 32(3-4): 105-15
  • 16. Spendlove J, Mitchell L, Gifford J, Hackett D, Slater G, Cobley S, et al. Dietary Intake of Competitive Bodybuilders. Sports Med. 2015; 45(7): 1041-63[DOI][PubMed]
  • 17. Tsochas K, Lazuras L, Barkoukis V. Psychosocial predictors of nutritional supplement use among leisure time exercisers. Performance Enhancement & Health. 2013; 2(1): 17-23[DOI]
  • 18. Thomas A, Tod DA, Edwards CJ, McGuigan MR. Drive for muscularity and social physique anxiety mediate the perceived ideal physique muscle dysmorphia relationship. J Strength Cond Res. 2014; 28(12): 3508-14[DOI][PubMed]
  • 19. Hildebrandt T, Langenbucher J, Schlundt DG. Muscularity concerns among men: development of attitudinal and perceptual measures. Body Image. 2004; 1(2): 169-81[DOI][PubMed]
  • 20. Ajzen I. The theory of planned behavior. Organizational behavior and human decision processes. 1991; 50(2): 179-211
  • 21. Flay BR, Snyder F, Petraitis J. The theory of triadic influence. Emerging theories in health promotion practice and research. 2009; 2: 451-510
  • 22. Smith AL. Measurement of social physique anxiety in early adolescence. Med Sci Sports Exerc. 2004; 36(3): 475-83[PubMed]
  • 23. Agah-Heris M, Janbozorgi M. The relationship between social physique anxiety, body mass index, and eating behaviors among university students. International Journal of Behavioral Sciences. 2012; 6(3): 205-12
  • 24. Olivardia R, Pope HJ, Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry. 2000; 157(8): 1291-6[DOI][PubMed]
  • 25. Wolke D, Sapouna M. Big men feeling small: Childhood bullying experience, muscle dysmorphia and other mental health problems in bodybuilders. Psychology of Sport and Exercise. 2008; 9(5): 595-604
  • 26. Conner M, Kirk SF, Cade JE, Barrett JH. Why do women use dietary supplements? The use of the theory of planned behaviour to explore beliefs about their use. Soc Sci Med. 2001; 52(4): 621-33[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments